An immunohistochemical comparison of two TTF-1 monoclonal antibodies in atypical squamous lesions and sarcomatoid carcinoma of the lung, and pleural malignant mesothelioma

Klebe, Sonja; Swalling, Adam; Jonavicius, Lisa; Henderson, Douglas W.
February 2016
Journal of Clinical Pathology;Feb2016, Vol. 69 Issue 2, p136
Academic Journal
Immunohistochemical detection of thyroid transcription factor-1 (TTF-1) plays an important role in the diagnosis and subclassification of non-small cell carcinomas of the lung in biopsy and some cytology samples, specifically for identification of squamous cell carcinoma (classically negative) and non-mucinous adenocarcinoma ( positive in most cases) and for discrimination between lung adenocarcinoma and pleural malignant mesothelioma (classically negative). Aims and methods We carried out a comparison of the widely used mouse monoclonal TTF-1 antibody based on the 8G7G3/1 clone versus the more recently introduced rabbit monoclonal antibody (MAb) based on the SP141 clone. Results Both antibodies labelled alveolar epithelium in normal lung parenchyma, but the SP141 antibody also labelled bronchial mucosal basal cells. All 13 cases of atypical squamous lesions (including one case of bronchial squamous dysplasia) were negative with the 8G7G3/1 antibody, but 6/13 cases of squamous carcinoma/dysplasia showed positive nuclear labelling with the SP141 antibody in the same tissue biopsy. All 35 cases of adenocarcinoma of the lung were positive with both antibodies. For 12 cases of sarcomatoid carcinoma of the lung, two cases were labelled with the 8G7G3/1 antibody, whereas positive labelling of 4/12 cases was observed with SP141. All 66 cases of epithelioid malignant mesothelioma were negative with both antibodies, but 8/19 cases of sarcomatoid mesothelioma showed positive nuclear labelling with the SP141 antibody (0/19 with 8G7G3/1). Conclusions Our findings indicate differences in the rates of positive and negative labelling with these two antibodies, and suggest the potential for misclassification of a proportion of squamous carcinomas of the lung as adenocarcinoma, and for misdiagnosis of some sarcomatoid mesotheliomas as sarcomatoid carcinoma of the lung. If the results of SP141 are assigned overriding significance, our findings further indicate that in isolation, neither negative labelling with either 8G7G3/1 or SP141 nor positive labelling with the SP141 MAb discriminates between sarcomatoid carcinoma and sarcomatoid mesothelioma, whereas positive labelling with the 8G7G3/1 MAb favours a diagnosis of sarcomatoid carcinoma. The literature suggests that these seemingly 'aberrant' results with the SP141 antibody are not 'false' positives, but rather real detection of low levels of TTF-1 protein in a broader range of tumours than is widely recognised.


Related Articles

  • The diagnostic utility of immunohistochemistry in distinguishing between epithelioid mesotheliomas and squamous carcinomas of the lung: a comparative study. Ordóñez, Nelson G. // Modern Pathology;Mar2006, Vol. 19 Issue 3, p417 

    As both mesotheliomas and squamous carcinomas can present a wide variety of morphological patterns, they can on occasion be confused. Recently, some groups of investigators have called attention to the difficulties that sometimes exist in distinguishing between these malignancies and the need to...

  • Therapeutic anti-EGFR antibody 806 generates responses in murine de novo EGFR mutant--dependent lung carcinomas. Danan Li; Hongbin Ji; Zaghlul, Sara; McNamara, Kate; Mei-Chih Liang; Shimamura, Takeshi; Kubo, Shigeto; Takahashi, Masaya; Chirieac, Lucian R.; Padera, Robert F.; Scott, Andrew M.; Jungbluth, Achim A.; Cavenee, Webster K.; Old, Lloyd J.; Demetri, George D.; Kwok-Kin Wong // Journal of Clinical Investigation;Feb2007, Vol. 117 Issue 2, p346 

    Activating EGFR mutations occur in human non-small cell lung cancer (NSCLC), with 5% of human lung squamous cell carcinomas having EGFRvIII mutations and approximately 10%–30% of lung adenocarcinomas having EGFR kinase domain mutations. An EGFR-targeting monoclonal antibody, mAb806,...

  • Prognostic value of hypoxia inducible factor 1α in esophageal squamous cell carcinoma. Munipalle, P. C.; Viswanath, Y. K. S.; Davis, P. A.; Scoones, D. // Diseases of the Esophagus;Apr2011, Vol. 24 Issue 3, p177 

    Hypoxia inducible factor 1α (HIF 1α) plays a major role in the pleitropic response observed secondary to hypoxic conditions in tumors. Its expression in the tumor cells has been correlated to tumor aggressiveness and prognosis in squamous cell carcinoma (SCC) of the esophagus in Far...

  • Claudin-4 as a Marker for Distinguishing Malignant Mesothelioma From Lung Carcinoma and Serous Adenocarcinoma. Ohta, Yoshiki; Sasaki, Yosuke; Saito, Mitsuji; Kushima, Miki; Takimoto, Masafumi; Shiokawa, Akira; Ota, Hidekazu // International Journal of Surgical Pathology;Oct2013, Vol. 21 Issue 5, p493 

    We compared claudin-4 with Ber-EP4 and carcinoembryonic antigen as markers to distinguish mesothelioma from lung adenocarcinoma, poorly differentiated lung squamous cell carcinoma, and serous adenocarcinoma of the uterus or ovary. All mesothelioma specimens were negative for claudin-4, but 3 of...

  • Lymphangiosis carcinomatosa in squamous cell carcinomas of larynx and hypopharynx - value of conventional evaluation and additional immunohistochemical staining of D2-40. Völker, Hans-Ullrich; Scheich, Matthias; Nowack, Isabell; Metzger, Alexandra; Haubitz, Imme; Puppe, Bernhard; Hagen, Rudolf; Müller-Hermelink, Hans-Konrad; Völter, Christiane // World Journal of Surgical Oncology;2009, Vol. 7, p1 

    Background: Recent studies revealed a predictive value of lymphatic vessel invasion (L1) for the nodal metastasizing and poor prognosis in malignant tumors at different sites. The monoclonal antibody D2-40 (podoplanin) stains specifically endothelial cells of lymphatic vessels and improves the...

  • CAXII Is a Sero-Diagnostic Marker for Lung Cancer. Kobayashi, Makoto; Matsumoto, Toshihide; Ryuge, Shinichiro; Yanagita, Kengo; Nagashio, Ryo; Kawakami, Yoshitaka; Goshima, Naoki; Shi-Xu Jiang; Saegusa, Makoto; Iyoda, Akira; Satoh, Yukitoshi; Masuda, Noriyuki; Yuichi Sato // PLoS ONE;Mar2012, Vol. 7 Issue 3, p1 

    To develop sero-diagnostic markers for lung cancer, we generated monoclonal antibodies using pulmonary adenocarcinoma (AD)-derived A549 cells as antigens by employing the random immunization method. Hybridoma supernatants were immunohistochemically screened for antibodies with AMeX-fixed and...

  • Nivolumab for second-line treatment of metastatic squamous non-small-cell lung cancer. ROUNDS, AMANDA; KOLESAR, JILL // American Journal of Health-System Pharmacy;11/1/2015, Vol. 72 Issue 21, p1851 

    Purpose. The pharmacokinetics, pharmacodynamics, efficacy, toxicity, and place in therapy of nivolumab, a novel immunotherapy agent for the treatment of advanced non-small-cell lung cancer (NSCLC) of the squamous cell subtype are reviewed. Summary. Nivolumab is a novel programmed cell death 1...

  • PATERNS OF THE VASCULAR ENDOTHELIAL GROWTH FACTOR IMMUNE-HISTOCHEMICAL EXPRESSION IN LUNG CARCINOMAS. Birau, Amalia; Ceausu, Raluca Amalia; Cimpean, Anca Maria; Gaje, Pusa; Ciobanu, Gheorghe; Olariu, Teodora; Raica, Marius // Studia Universitatis Vasile Goldis Seria Stiintele Vietii (Life ;2012, Vol. 22 Issue 1, p11 

    Vascular endothelial growth factor (VEGF) has been demonstrated as the main angiogenic molecule in vitro and in vivo. The involvement of VEGF in the prognosis and progression of different types of tumors has been demonstrated by many publications. In the present study we have investigated the...

  • Analysis of the E-Cadherin Repressor Snail in Primary Human Cancers. Becker, K.-F.; Rosivatz, E.; Blechschmidt, K.; Kremmer, E.; Sarbia, M.; Höfler, H. // Cells Tissues Organs;2007, Vol. 185 Issue 1-3, p204 

    Epithelial-mesenchymal transition (EMT), a normal developmental process, is known to play a crucial role in tumor progression. Molecules involved in this process, such as the E-cadherin repressor Snail, facilitate migration and invasion of carcinoma cells. A growing number of studies addressing...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics